Orasis Pharmaceuticals logoOP

Orasis Pharmaceuticals

Verified

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical

About Orasis Pharmaceuticals

Orasis Pharmaceuticals builds in the healthcare category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.

What they do: Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical

Funding context: Sequoia, $30M Series C in 2020

Recent milestones:

  • Orasis Pharmaceuticals appears in the 100Xfounder startup directory import feed.

Why it Matters

Orasis Pharmaceuticals matters because orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical

Funding Snapshot

Total Funding: $30.00MLast Round: Series C Sequoia, $30M Series C in 2020All Rounds: 1
  • Series C | Sequoia, $30M Series C in 2020

Hiring Roles

No active hiring signal detected.

Meet the Founders

Orasis Pharmaceuticals Team

Orasis Pharmaceuticals Team

Founder & CEO

LinkedIn

Tech Stack

PythonGCPBigQueryReact

Last updated: April 17, 2026

Orasis Pharmaceuticals intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to Orasis Pharmaceuticals.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Orasis Pharmaceuticals

Common questions people ask about this profile.

What is Orasis Pharmaceuticals?

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical

Who founded Orasis Pharmaceuticals?

Orasis Pharmaceuticals is associated with Orasis Pharmaceuticals Team on 100Xfounder.

Where is Orasis Pharmaceuticals located?

Orasis Pharmaceuticals is listed in Tel Aviv, Israel.

What stage is Orasis Pharmaceuticals in?

Orasis Pharmaceuticals is currently mapped to Series C. Funding context: Sequoia, $30M Series C in 2020

What is the latest funding round of Orasis Pharmaceuticals?

Orasis Pharmaceuticals's latest tracked round is Series C Sequoia, $30M Series C in 2020. Total tracked rounds: 1.

Is Orasis Pharmaceuticals hiring now?

Orasis Pharmaceuticals hiring status: no active hiring signal.

What technologies does Orasis Pharmaceuticals use?

Orasis Pharmaceuticals is associated with Python, GCP, BigQuery, and React.

Is Orasis Pharmaceuticals verified on 100Xfounder?

Yes. Orasis Pharmaceuticals is currently marked verified on 100Xfounder as of April 17, 2026.

How can users connect with Orasis Pharmaceuticals founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.